Tight Florida Senate and governor races head to a recount
Republican Rick Scott holds slight lead over Democrat Sen. Bill Nelson
All Posts in "Markets"
‘Keep talkin’ Larry’: Amazon appears ever closer to dumping Oracle
Amazon indicates it’s a step closer to eliminating its long reliance on software from Oracle, which competes with its own AWS
Hertz stock jumps as company’s earnings beat revives turnaround hopes
Hertz shares were on track for their best close in more than a month
FTSE 100 ends lower as resource stocks, banks retrace gains
Growth data overlooked as market frets over Fed
Bitcoin down 1%, heading toward lowest level of the week
Bitcoin prices are trading lower Friday, on track for back-to-back losing sessions for the first time since late October.
Which markets are closed on Veterans Day?
Not many — bond markets are closed, but all other markets are open for business
Europe stocks slide into close but finish week higher
Thyssenkrupp, Telecom Italia tumble on results
Yelp’s post-earnings stock plunge exposes a fragile business model yet again
After Yelp moved to offer ads without long-term deals, business owners are ducking sales reps’ calls
Why no one is popping champagne over China’s buoyant export data
Worries about how the U.S.-China trade spat will play out weighs on investors
China, Hong Kong lead Asian markets lower with financials under pressure
Nikkei falls from multi-week high; Hang Seng drops 2.5%
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis